Box score
Quince Therapeutics, Inc.
Reported $115M sold in a new Form D filed June 11, 2026 (South San Francisco, California).
- Biggest raise
- $115M filed Jun 11, 2026
- League
- Bio & Health Biotechnology
- Based in
- South San Francisco, California
- Season rank
- #11 of 1,121 in the Bio & Health League; #172 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-06-11 | New notice not ranked | $0 | $7.4M | SEC |
| 2026-06-11 | New notice | $115M | $186M | SEC |
| 2025-07-01 | New notice | $11.5M | $21.9M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1662774.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Jasper Therapeutics, Inc. rookie | Bio & Health | $132M |
| 2 | SonoThera, Inc. | Bio & Health | $125M |
| 3 | Rakuten Medical, Inc. | Bio & Health | $112M |
| 4 | Candid Group, Inc. rookie | Bio & Health | $105M |
| 5 | Imperative Care, Inc. | Bio & Health | $100M |
| 6 | Alpfa Medical, Inc. rookie | Bio & Health | $80.3M |